Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Obesity 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Non-alcoholic Fatty Liver Disease 1Neoplasms 1Infections 1Barrett Esophagus 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Docosahexaenoic Acids × Clear all
NCT03147586 2017-05-10

Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy

Mansoura University

Phase 4 Unknown
100 enrolled
Genitourinary

Urinary Bladder Neoplasms, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡